AmerisourceBergen To Pay $260M After Mislabeling Drugs

Law360, New York (September 27, 2017, 3:15 PM EDT) -- A subsidiary of pharmaceutical giant AmerisourceBergen Corp. pled guilty Wednesday in a Brooklyn federal court to violating federal rules on the packaging and distribution of drugs and agreed to pay $260 million in fines and forfeiture.

An Alabama subsidiary of AmerisourceBergen Specialty Group opened sterile vials of oncology drugs, pooled the medicine and transferred the drugs into single-dose prefilled syringes, according to a stipulated statement of facts. (AP) AmerisourceBergen Specialty Group sent its attorney, Eric Sitarchuk of Morgan Lewis & Bockius LLP, to plead guilty before U.S. District Judge Nina Gershon in a bloodless hearing that featured neither an oral allocution...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS